Follow Us On

Facebook  X  Linkedin  YouTube
 
 

Advance Your Skills This August

with ASIPP's Hands-On Workshops


Join ASIPP this August at the Medical Education & Research Institute (MERI) in Memphis, Tennessee for these hands-on educational workshops:



ACCOMMODATIONS

The Westin Memphis, Beale Street

170 Lt. George W Lee Ave, Memphis, TN 38103

901-334-5900


Click Here to Book Your Room

Cut-off date for special room rates: August 13, 2026.

In order to ensure you receive the discounted room block rate of $189 plus tax per night let the hotel know you are with the ASIPP workshops.


Space is limited for these workshops.

Early registration is encouraged.

FRIDAY, AUGUST 28



Ultrasound for Regenerative Medicine Hands-On Workshop



Earn 8 CMEs while gaining practical ultrasound experience focused on regenerative medicine applications.


SATURDAY, AUGUST 29



Regenerative Medicine Hands-On Cadaver Workshop

(Basic, Intermediate, & Advanced)



Earn 8 CMEs in this cadaver workshop with hands-on instruction covering regenerative medicine techniques across varying experience levels.

SATURDAY, AUGUST 29



Interventional Techniques in IPM Hands-On Cadaver Workshop

(Basic, Intermediate & PNS)


Earn 8 CMEs in this workshop focused on interventional pain management techniques and peripheral nerve stimulation applications.

House Passes Bill to Ease Quality Reporting Requirements for Medicare ACOs 

Some programs would be able to continue using one of three current systems through 2029


Physician practices participating in a Medicare accountable care organization (ACO) may have an easier time submitting quality data to Medicare if a bill passed Monday by the House becomes law.


H.R. 5347, the Health Care Efficiency Through Flexibility Act, would allow Medicare ACOs to continue to collect quality data through three types of measures -- electronic clinical quality measures (eCQMs), Merit-Based Incentive Payment System clinical quality measures, and Medicare clinical quality measures -- through performance year 2029. Previously, ACOs were supposed to begin using only eCQMs starting last year, according to a regulation issued by CMS in 2024.


The bill applies specifically to the Medicare Shared Savings Program, one of the more popular forms of Medicare ACOs. ACOs are groups of doctors, hospitals, and other healthcare professionals that work together to give patients high-quality, coordinated service and healthcare, improve health outcomes, and manage costs, according to CMS.


The measure, which was passed by a voice vote, also requires CMS to establish a pilot program to test other digital reporting methods for ACOs. The pilot program, which would run from 2028 to 2032, would exempt ACOs that participate in it from using other reporting methods; once it ends, CMS would be required to publicly post an analysis of the program and any related recommendations.


Click here to read the full article.

The Pain Physician journal has published updated, evidence-based guidelines for facet joint interventions in the management of chronic spinal pain.


Developed by a multidisciplinary panel of 48 authors, these guidelines include 37 recommendations, all achieving 100% acceptance through a modified Delphi process. The recommendations are based on a comprehensive evidence review, with evidence and recommendation strength assessed using modified ASIPP methodology, GRADE, and AHRQ criteria.


The document addresses patient selection, diagnostic facet joint nerve blocks, imaging guidance, radiofrequency ablation, therapeutic facet joint nerve blocks, intraarticular injections, repeat interventions, sedation, antithrombotic therapy, and special safety considerations.




Alcohol’s Health Myth Is Over. How to Tell Patients 



For nearly 30 years, the media and many physicians promoted the belief — fueled by the French paradox and bias-ridden observational studies — that a drink or two a day could be good for many adults.


Now, better-designed research has uncorked a new truth: Even one drink a day can raise the risk for cancer, cardiovascular problems, liver disease, and early death. The government-commissioned Alcohol Intake and Health Study, published in June, found a level of drinking once considered potentially protective — a glass of red wine with friends, a beer on a summer night, a brunch-time cocktail — have no meaningful health benefits.


The study joins a growing body of research presenting physicians with a challenge: How to explain to patients, even light drinkers, that older studies were flawed, and the healthiest drink is none at all.


“The science is evolving in front of our eyes. That can be deeply unsettling, but it’s an opportunity to engage our patients in the conversation,” said oncologist Noelle LoConte, MD, an associate professor at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin, and lead author of the American Society of Clinical Oncology’s most recent statement on alcohol and cancer.


Click here to read the full article.

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.

After Recent Leadership Departures, Is the FDA Returning to Form? 

Experts clash over significance of agency's reversals on certain rare disease drugs



Some experts say the FDA's recent change of heart on a handful of drugs for rare diseases suggests a return to regular order after a tumultuous year, while others argue the flip-flopping signals more chaos.


During the tenure of former FDA Commissioner Marty Makary, MD, MPH, and the agency's top vaccine official Vinay Prasad, MD, MPH, several rare disease drugs were rejected or sponsors were asked to complete additional studies.


For example, in January, the FDA sent a complete response letter to Atara Biotherapeutics and its partner Pierre Fabre Pharmaceuticals rejecting the T-cell immunotherapy tabelecleucel (Ebvallo) for the treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disease. The next month, the agency rejected Regenxbio's gene therapy RGX-121 for mucopolysaccharidosis II, also known as Hunter syndrome.


Then in March, the FDA closed the door on an accelerated approval of AMT-130, uniQure's treatment for Huntington's disease, sparking controversy by recommending a sham surgery-controlled study. Finally, in April, the agency panned Replimune's drug candidate for treating advanced melanoma.


Click here to read the full article.

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


No additional cost for ASIPP members!



An Old Theory Is Powering a New Approach to Doctor Burnout




We all know the toll of physician burnout: medical errors, reduced empathy, and doctors leaving the field entirely. About 45% of US physicians report at least one symptom of the condition.


Researchers have devoted thousands of studies to the problem, but a compelling solution is gaining traction in the literature — one that views burnout through the lens of a decades-old psychology framework known as self-determination theory (SDT). The idea: When a person’s core psychological needs are met, they are more motivated, engaged, and effective. In medicine, this makes for happier doctors and better patient care.


“Medicine has long operated as though clinician well-being and patient care are competing priorities,” said Adam Neufeld, MSc, MD, CCFP, a family medicine physician and clinical lecturer at the University of Calgary in Calgary, Alberta, Canada, who studies the application of SDT in healthcare. “SDT helps us see that supporting clinicians’ basic psychological needs is not a luxury or reward — it is a prerequisite for the high-quality care that patients deserve.” 


A gap remains between theory and practice, but SDT’s principles are being used more in medicine, not just in how residents are trained but also in how doctors communicate with patients. Medscape Medical News spoke with SDT researchers to understand how this framework works — and how to put it into action.


Click here to read the full article.


Apply now for one of the following 2026 dates:


July 25, September 26, October 24, November 14,& December 12



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam


August 28, 2026


  • ABIPP Part II Oral and Practical Examination

Topics that will be covered:

Caudal epidural injections; Lumbar interlaminar epidural injections; Lumbar/sacral transforaminal epidural injections; Cervical epidural injections; Thoracic epidural injections; Lumbar/sacral medial branch and L5 dorsal ramus blocks; Cervical medial branch blocks; Thoracic medial branch blocks; Lumbar/sacral facet joint nerve radiofrequency neurolysis; Cervical medial branch radiofrequency neurolysis; Thoracic medial branch radiofrequency neurolysis; Sacroiliac joint injections; Cervical sympathetic blocks; Lumbar paravertebral sympathetic blocks; Intercostal nerve blocks; Lumbar discography; Celiac plexus blocks (not Splancnic nerve blocks); Percutaneous epidural adhesiolysis; Spinal cord stimulation lead placement

Exam Dates

Our Sponsor

Our Sponsor

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Peripheral Low Frequency Versus High Frequency Nerve Stimulation: A Case Series


Alvise Martini, MD, Felice Occhigrossi, MD, Vittorio Schweiger, MD, Roberto Gazzeri, MD, and Enrico Polati, MD

Recurrent Lumbar Disc Herniations in an Adolescent Patient: A Case Report and Review of Management Challenges


Alex Landau, MD, Kevin Batti, MD, Moorice Caparo, MD, and Monika Desai, MD

Use of Temporary Peripheral Nerve Stimulation for Management of Recalcitrant Pain in Patients With Complex Regional Pain Syndrome: Case Series and Literature Review


Neha Singh, MD, and Emanuel N. Husu, MD

 

Special Guidelines Issue

Updated Facet Joint Interventions

GUIDELINES

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines


Laxmaiah Manchikanti, MD, Mahendra R. Sanapati, MD, Sheri L. Albers, DO, Alan D. Kaye, MD, PhD, Vinita Singh, MD, Nebojsa Nick Knezevic, MD, PhD, Rajesh Naidu Janapala, MD, Amol Soin, MD, Annu Navani, MD, Adam M. Kaye, PharmD, Ahad Mussarat, MD, Alexander Bautista, MD, Dajie Wang, MD, Paul J. Christo, MD, Maged Mina, MD, Daneshvari R. Solanki, MD, Devi Nampiaparampil, MD, Gerard Limerick, MD, PhD, John Manor, DO, Kris Ferguson, MD, Lynn Cintron, MD, Michael Bottros, MD, Shirley Chen, MS, Shivam S. Shah, MD, Vahid Grami, MD, MPH, Douglas P. Beall, MD, Shalini Shah, MD, Sairam Atluri, MD, Mittal S. Prajapati, MD, Alaa Abd-Elsayed, MD, Salahadin Abdi, MD, PhD, Steve Aydin, DO, Sanjay Bakshi, MD, Joseph Cabaret, MD, Aaron K. Calodney, MD, Kenneth D. Candido, MD, Christopher G. Gharibo, MD, Mayank Gupta, MD, Michael Harned, MD, Standiford Helm II, MD, Sachin "Sunny" Jha, MD, Radomir Kosanovic, MD, Vidyasagar Pampati, MSC, Ramarao Pasupuleti, MD, Bradley W. Wargo, DO, Hermant Kalia, MD, Gary Schwartz, MD, and Joshua A. Hirsch, MD

SYSTEMATIC REVIEW

An Updated (2026) Best-Evidence Synthesis Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal Pain


Laxmaiah Manchikanti, Mark V. Boswell, Mahendra R. Sanapati, Alan D. Kaye, Miles Day, Nebojsa Nick Knezevic, Mittal S. Prajapati, Amol Soin, Annu Navani, Vidyasagar Pampati, Christopher G. Gharibo, Devi Nampiaparampil, Vivek Manocha, Navneet Boddu, Sairam Atluri, Shalini Shah, Alexander Bautista, Vinita Singh, and Joshua A. Hirsch




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!